Mason James Smith, OTR/L | |
311 West Cedar Street, Binger, OK 73009-7300 | |
(405) 545-0864 | |
Not Available |
Full Name | Mason James Smith |
---|---|
Gender | Male |
Speciality | Occupational Therapist |
Location | 311 West Cedar Street, Binger, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578938288 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 5648 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mason James Smith, OTR/L Po Box 41, Binger, OK 73009-0041 Ph: (405) 545-0864 | Mason James Smith, OTR/L 311 West Cedar Street, Binger, OK 73009-7300 Ph: (405) 545-0864 |
News Archive
The Guardian profiles Brian Brink, chief medical officer at Anglo American, South Africa's largest private-sector employer, and the company's efforts to treat and prevent HIV among its employees.
According to sexologist Bettina Arndt, there are thousands of Australian men with erectile dysfunction who are sexually impotent because of their condition and the lack of affordable treatments. Arndt said that funds distribution for breast prostheses for female cancer patients is one of the examples of mismatches in funding.
Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
Depression and other emotional symptoms in survivors of torture and other traumatic experiences may be exacerbated by the effects of head injuries, according to a study from the Harvard Program in Refugee Trauma (HPRT), based in the Massachusetts General Hospital (MGH) Department of Psychiatry.
In an article published in The Lancet Oncology, an NCI (US National Cancer Institute), NCRI (UK National Cancer Research Institute), and EORTC (European Organisation for Research and Treatment of Cancer) working group outline a practical risk-management approach for effective integration of biomarkers into cancer clinical trials.
› Verified 6 days ago